StonvexLoading…
StonvexStonvexStonvexCore line items from BSY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $424.18M | $1.50B | $1.11B | $734.65M |
Operating Income | $126.26M | $362.62M | $284.11M | $199.61M |
Net Income | $95.39M | $277.86M | $219.22M | $161.85M |
EPS (Diluted) | $0.30 | $0.85 | $0.67 | $0.50 |
Total Assets | $3.52B | $3.56B | $3.46B | $3.42B |
Total Liabilities | $2.30B | $2.37B | $2.27B | $2.26B |
Cash & Equivalents | $105.16M | $123.28M | $165.41M | $89.65M |
Free Cash Flow OCF − CapEx | $187.86M | $520.21M | $384.04M | $273.37M |
Shares Outstanding | 321.84M | 333.09M | 333.21M | 333.15M |